Citadel Advisors’s Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PNTM.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-652,638
Closed -$112K 15683
2023
Q1
$112K Sell
652,638
-353,394
-35% -$77.5K ﹤0.01% 11090
2022
Q4
$80.5K Sell
1,006,032
-10,881
-1% -$589 ﹤0.01% 11527
2022
Q3
$60K Sell
1,016,913
-1,841
-0.2% -$180 ﹤0.01% 11504
2022
Q2
$135K Sell
1,018,754
-489
-0% -$108 ﹤0.01% 11094
2022
Q1
$331K Buy
1,019,243
+23,650
+2% +$11.2K ﹤0.01% 10363
2021
Q4
$886K Buy
995,593
+72,984
+8% +$58.7K ﹤0.01% 8254
2021
Q3
$663K Sell
922,609
-62,201
-6% -$52.4K ﹤0.01% 9199
2021
Q2
$975K Buy
984,810
+136,451
+16% +$113K ﹤0.01% 8431
2021
Q1
$637K Buy
+848,359
New +$850K ﹤0.01% 9147

Citadel Advisors's PNTM.WS Position: Q2 2023 in Review

Citadel Advisors sold out of Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PNTM.WS) in Q2 2023, closing a stake of 652,638 shares — an estimated $112K sold.

Citadel Advisors first reported a position in PNTM.WS in Q1 2021 and held it in 9 quarters. The position peaked at $975K in Q2 2021. 0 funds tracked by Wall St. Rank hold PNTM.WS as of Q2 2023.

  • Citadel Advisors reported no remaining Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 652,638 Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $112K.
  • Citadel Advisors first reported a position in Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 9 quarters.
  • Citadel Advisors's Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $975K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.